BioSenic S.A. (EBR:BIOS)
Belgium · Delayed Price · Currency is EUR 0.0023
-0.0001 (-4.17%)
At close: Dec 5, 2025
BioSenic Market Cap
BioSenic has a market cap or net worth of €1.5 million as of December 5, 2025. Its market cap has decreased by -2.11% in one year.
Market Cap
1.50M
Enterprise Value
24.53M
Revenue
-2.39M
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.00
Market Cap Chart
Since October 26, 2022, BioSenic's market cap has decreased from 7.09M to 1.50M, a decrease of -78.83%. That is a compound annual growth rate of -39.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 1.50M | -20.08% |
| Dec 31, 2024 | 1.88M | -81.19% |
| Dec 29, 2023 | 9.99M | 233.11% |
| Dec 30, 2022 | 3.00M | -57.74% |
| Oct 26, 2022 | 7.09M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| argenx SE | 47.82B |
| UCB SA | 46.17B |
| Financière de Tubize | 9.39B |
| Fagron NV | 1.53B |
| Ion Beam Applications | 323.10M |
| Onward Medical | 186.12M |
| Hyloris Pharmaceuticals | 170.24M |
| Nyxoah | 156.37M |